Prostate Cancer
Prostate Cancer
Advertisement
Tamara ThomasProstate Cancer | November 19, 2024
transgender status was not a predictor of prostate cancer-related death.
Read More
Rebecca AraujoASTRO 2024 | November 18, 2024
These findings highlight the importance of racial diversity in genomic profiling and clinical trials.
Rebecca AraujoASTRO 2024 | October 22, 2024
Men aged 60-69 years had a decreased risk of death with the addition of androgen deprivation therapy.
Rebecca AraujoASTRO 2024 | October 21, 2024
The adoption of polyethylene glycol hydrogel spacer use in prostate cancer care has been slower in Black patients.
Rebecca AraujoASTRO 2024 | October 15, 2024
Guideline-concordant androgen deprivation therapy is associated with a survival benefit in high-risk prostate cancer.
Rebecca AraujoASTRO 2024 | October 14, 2024
Patients who underwent radical prostatectomy also had a higher likelihood of decision regret.
Tamara ThomasASTRO 2024 | October 17, 2024
Both Fluciclovine and PSMA PET/CT guided radiation therapy would significantly change pre-PET radiation therapy volumes.
Tamara ThomasASTRO 2024 | October 10, 2024
P-CARE integrates genetics, family history, and ancestry to offer a more objective risk assessment.
Tamara ThomasASTRO 2024 | October 17, 2024
After 10 years, 3.3% of patients who were recurrence-free developed distant metastasis.
Tamara ThomasASTRO 2024 | October 3, 2024
High-risk genomic classifiers were associated with a 10-fold higher risk of prostate cancer.
Tamara ThomasASTRO 2024 | October 3, 2024
The use of gender-affirming hormone therapy was associated with lower PSA levels compared with cisgender men.
Tamara ThomasASTRO 2024 | October 2, 2024
MRI guidance helps to reduce the amount of healthy tissue targeted during radiation therapy for prostate cancer.
Tamara ThomasASTRO 2024 | October 2, 2024
Advanced radiotherapy using fewer, stronger doses delivered similar quality-of-life outcomes and side effects.
Tamara ThomasProstate Cancer | August 14, 2024
The results revealed that Black men had greater microvascular dysfunction compared with White males.
Tamara ThomasProstate Cancer | July 29, 2024
prostate cancer cases is expected globally, with numbers doubling to 2.9 million and deaths increasing by 85%
Lou PorteroProstate Cancer | March 5, 2024
Black men are more likely to be diagnosed with and die from prostate cancer.
Tamara ThomasProstate Cancer | January 22, 2024
"Prostate cancer cells (are) producing more cholesterol, which they divert to generate their own androgen."
Tamara ThomasProstate Cancer | January 8, 2024
Black participants were significantly less likely to use NHT compared to other racial and ethnic groups.
Lou PorteroProstate Cancer | December 27, 2023
Researchers found that men from indigenous men were more likely to have higher PSA compared to non-Indigenous men.
Lou PorteroProstate Cancer | November 20, 2023
Asian PCa patients had longer median overall survival than White patients.
Advertisement
Advertisement
Advertisement
Latest News

November 21, 2024